Viewing Study NCT01384461


Ignite Creation Date: 2025-12-24 @ 12:08 PM
Ignite Modification Date: 2025-12-25 @ 5:49 PM
Study NCT ID: NCT01384461
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2011-06-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (ACTIVATE)
Sponsor: Hoffmann-La Roche
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-01
Start Date Type: None
Primary Completion Date: 2013-05
Primary Completion Date Type: ACTUAL
Completion Date: 2013-05
Completion Date Type: ACTUAL
First Submit Date: 2011-06-28
First Submit QC Date: None
Study First Post Date: 2011-06-29
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-11-01
Last Update Post Date: 2016-11-02
Last Update Post Date Type: ESTIMATED